Mini review · 31 Aug 2022
Research articlePublished 22 Apr 2017
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections and Current Research Trends
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Methicillin-Resistant Staphylococcus aureus (MRSA), manifested as a primary cause of skin infections, was invasive among healthy adults and children with clinical, epidemiologic, and bacteriologic characteristics distinct from healthcare-associated MRSA (HA-MRSA) resulting in increased length of hospitalization, healthcare costs and increased mortality. Nonetheless, vancomycin 1 was considered as the standard therapy. However, the limitations of vancomycin 1 application in clinical practice were represented by a progressive increase in Methicillin Resistant S. aureus (MRSA) Minimum Inhibitory Concentrations (MIC), drug-related toxicity, and the lack of an oral formulation. Vancomycin 1 might be inferior to beta-lactams for bacteremia treatment because of Methicillin Susceptible Staphylococcus aureus (MSSA) in children. Vancomycin 1, a glycopeptide antibiotic, was first isolated in 1953 as a natural occurring antimicrobial agent produced by soil bacterium Amycolatopsis orientalis. Vancomycin 1 was approved for use in 1958 as a common antibiotic in treating rapidly growing penicillin-resistant Staphylococcus species. However, this antibiotic was not a primary choice of the treatment owing to its poor oral bioavailability and its various adverse effects. The evolution of Pseudomembranous enterocolitis, coupled with the spread of Methicillin Resistant Staphylococcus aureus (MRSA), led to the re-emergence of positive bacteria that were resistant to less-toxic agents. In addition, vancomycin 1 was used in patients who were intolerant or allergic to beta-lactams. This review encapsulates the strategies for the clinical management of MRSA.
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2012
Use of restriction fragment length polymorphism to characterize methicillin-resistant Staphylococcus aureus in dairy products
Conference abstract
Prevalence of methicillin-resistant Staphylococcus aureus among health care workers in Tripoli Hospital, Libya
Conference abstract · 29 Aug 2020
The Comparison of ica AD Genes in Methicillin resistant staphylococcus aureus (MRSA) biofilm producing between healthcare workers in hospital and general population in Banyumas district, Indonesia
Conference abstract · 15 Aug 2016
Methicillin resistant staphylococcus aureus (MRSA) : Awareness and knowledge among Mansoura university students : A field study
More from this journal
The newest in Archives of General Internal Medicine.
Editorial · 13 May 2026
Optimizing patient risk: Pharmacology and diagnostics
Editorial · 13 May 2026
Pulmonary function and sleep disorders: An integrated approach
Editorial · 13 May 2026
Cardiac imaging, hemodynamics, and arrhythmia management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of General Internal Medicine
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Robert Gallagher”
- BylineArticles whose byline prints “Noburu Motohashi”
- BylineArticles whose byline prints “Anuradha Vanam”
- BylineArticles whose byline prints “Rao Gollapudi”

